Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine

This study has been completed.
Information provided by (Responsible Party):
Hualan Biological Engineering, Inc. Identifier:
First received: January 18, 2012
Last updated: August 13, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)